Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1200 of 3173 entries
View as:

Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients

Phase: N/A Priority: Normal
NCT ID: NCT04398732 Org: User:
Start: 07/05/20 End: 10/01/20 Due: 10/01/21

Korean Post Marketing Surveillance for ELREXFIO (Elranatamab).

Phase: N/A Priority: Normal
NCT ID: NCT06581848 Org: User:
Start: 06/05/25 End: 05/29/30 Due: 05/29/31

A Multicenter, Randomized, Double-Blind, Double-Dummy Study Of Azithromycin SR Versus Amoxicillin For The Treatment Of Strep Throat In Children

Phase: N/A Priority: Normal
NCT ID: NCT00643149 Org: User:
Start: 05/31/03 End: 03/31/04 Due: 03/31/05

A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT05348915 Org: User:
Start: 03/29/22 End: 11/04/28 Due: 11/04/29

Effect of PF-06651600 on the Pharmacokinetics of Oral Contraceptive Steroids

Phase: N/A Priority: Normal
NCT ID: NCT04018274 Org: User:
Start: 08/09/19 End: 10/16/19 Due: 10/16/20

Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations

Phase: N/A Priority: Normal
NCT ID: NCT03185481 Org: User:
Start: 07/06/17 End: 10/25/17 Due: 10/25/18

An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis

Phase: N/A Priority: Normal
NCT ID: NCT00826514 Org: User:
Start: 03/25/09 End: 03/17/10 Due: 03/17/11

Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01763164 Org: User:
Start: 07/12/13 End: 06/04/19 Due: 06/04/20

A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation

Phase: N/A Priority: Normal
NCT ID: NCT00141206 Org: User:
Start: 05/31/03 End: 04/30/05 Due: 04/30/06

A Long-Term, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT00565812 Org: User:
Start: 11/30/07 End: 11/30/11 Due: 11/30/12

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01399840 Org: User:
Start: 06/30/11 End: 05/31/14 Due: 05/31/15

First In Human, Single Escalating Oral Dose Study Of PF-06882961 In Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03309241 Org: User:
Start: 10/17/17 End: 03/22/18 Due: 03/22/19

TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)

Phase: N/A Priority: Normal
NCT ID: NCT05548127 Org: User:
Start: 02/23/23 End: 09/25/25 Due: 09/25/26

A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03148795 Org: User:
Start: 07/04/17 End: 03/31/23 Due: 03/31/24

A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00814307 Org: User:
Start: 02/28/09 End: 06/30/10 Due: 06/30/11

Pharmacokinetics Of Azithromycin Immediate Release And Extended Release Formulation In Kids With Acute Otitis Media

Phase: N/A Priority: Normal
NCT ID: NCT00796224 Org: User:
Start: 12/31/08 End: 02/28/09 Due: 02/28/10

A Study Of The Safety And Effects Of One Or More Doses Of HSP-130 Injected Under The Skin In Women With Breast Cancer That Has Not Spread To Distant Sites In The Body.

Phase: N/A Priority: Normal
NCT ID: NCT02650193 Org: User:
Start: 12/31/15 End: 10/31/17 Due: 10/31/18

Randomized, Double Blind, Multicenter Study of the Safety and Efficacy of Valdecoxib 40 mg Once Daily Compared With Diclofenac 75 mg Twice Daily in Acute Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT00649610 Org: User:
Start: 11/30/02 End: 05/31/03 Due: 05/31/04

A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01947894 Org: User:
Start: 11/20/13 End: 10/31/18 Due: 10/31/19

A Study To Investigate The Absorption, Distribution, Metabolism, And Excretion Of [14c]PF-06463922 In Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02564562 Org: User:
Start: 10/31/15 End: 11/30/15 Due: 11/30/16

Current Adoption of Composite Indices in Evaluating Rheumatoid Arthritis Patients: An Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT00793403 Org: User:
Start: 01/31/08 End: 06/30/10 Due: 06/30/11

A Multicenter Extension Study of Taliglucerase Alfa in Pediatric Subjects With Gaucher Disease

Phase: N/A Priority: Normal
NCT ID: NCT01411228 Org: User:
Start: 09/30/11 End: 08/31/14 Due: 08/31/15

Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT01602874 Org: User:
Start: 01/31/11 End: 05/31/14 Due: 05/31/15

Comparative Analysis of Outcomes Among Patients Initiating Xeljanz in Combination With Oral MTX Who Withdraw MTX Versus Continue MTX

Phase: N/A Priority: Normal
NCT ID: NCT03975790 Org: User:
Start: 05/29/18 End: 10/02/18 Due: 10/02/19

An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02475746 Org: User:
Start: 07/31/15 End: 08/31/15 Due: 08/31/16